Legal And Ethical Regulation Of Drug Delivery Systems In Clinical Practice
International Journal of Drug Delivery Technology · 23.04.2026 · 16 (16s)
DOI: 10.25258/ijddt.16.16s.89 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 23.04.2026. Verfasst von Ms. Alka Rani und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Drug delivery systems (DDS) have become an important aspect of the pharmaceutical innovation today, allowing both targeted delivery of drugs, controlled release of therapeutic agents and enhancing efficacy of treatment. The emerging, sophisticated drug delivery technologies, such as nanomedicine, implantable devices, and custom drug delivery systems, have brought new regulatory and ethical issues to health care systems around the globe. The research paper under discussion deals with the legal and ethical regulation of drug delivery systems in clinical practice by combining regulatory policy analysis with primary empirical data. Numerous questions were used to develop a structured questionnaire based on Google Forms to measure the stakeholder attitude toward regulatory governance, ethical issues, and clinical application of advanced DDS technologies (30 questions). There were 98 valid responses collected and analyzed with the help of descriptive statistical methods. The results show that medical practitioners are very familiar with the regulatory bodies like the U.S Food and Drug Authority, the European Medicine Agency and the national pharmaceutical regulatory bodies. Nevertheless, the respondents also listed a number of governance issues surrounding emerging technology in drug delivery including regulatory lapses in nanotechnology regulation, drug delivery systems based on artificial intelligence as well as personalized medicine. Informed consent and patient safety ethical issues and risk and benefit assessment were also noted to be critical in clinical drug delivery research. The research highlights the need to create a balance between technological innovation and regulatory regulation in order to have safe and responsible advancement of pharmaceutical advanced technologies. The findings indicate that the new regulation systems, the enhanced accountability systems, and the global regulation collaboration are required to deal with the emerging issues in delivery systems of drugs. Combining legal, ethical, and scientific views, the study forms part of the overall knowledge base of governance techniques that are needed to achieve responsible development of drug delivery technologies in healthcare today.
Zitieren
APA
Rani, M. A., Thakur, D. K., Mdhara, M. R., Singh, P. D. R., Bangarh, D. P., & Singh, B. (2026). Legal And Ethical Regulation Of Drug Delivery Systems In Clinical Practice. International Journal of Drug Delivery Technology, 16(16s). https://doi.org/10.25258/ijddt.16.16s.89
Vancouver
Rani MA, Thakur DK, Mdhara MR, Singh PDR, Bangarh DP, Singh B. Legal And Ethical Regulation Of Drug Delivery Systems In Clinical Practice. International Journal of Drug Delivery Technology. 2026;16(16s). doi:10.25258/ijddt.16.16s.89
BibTeX
@article{Rani2026,
author = {Rani, Ms. Alka and Thakur, Dr. Kalpana and Mdhara, Mr. Rahul and Singh, Prof. (Dr.) Raghuvinder and Bangarh, Dr Pinky and Singh, Bineet},
title = {Legal And Ethical Regulation Of Drug Delivery Systems In Clinical Practice},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {16s},
doi = {10.25258/ijddt.16.16s.89}
}
EUVIMED